Receives Development Milestone Payment of CTX-177 (ONO-7018), a MALT1 Inhibitor according to License Agreement with Ono Pharmaceutical

Please find below link

Chordia receives Development Milestone Payment of CTX-177 (ONO-7018), a MALT1 Inhibitor according to License Agreement with Ono Pharmaceutical.（PDF）